Cargando…
Significance of cardiovascular comorbidity in patients with chronic myelomonocytic leukemia
In a retrospective study, we analyzed the prevalence of common cardiovascular comorbidities in 310 patients with chronic myelomonocytic leukemia (CMML), their potential prognostic impact, and potential correlations with laboratory and molecular features. 115 (36%) patients had a documented cardiovas...
Autores principales: | Lackner, David, Geissler, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877056/ https://www.ncbi.nlm.nih.gov/pubmed/36414855 http://dx.doi.org/10.1007/s10354-022-00982-7 |
Ejemplares similares
-
Significance of hypergammaglobulinemia in patients with chronic myelomonocytic leukemia
por: Zack, Marie-Therese, et al.
Publicado: (2022) -
Significance of reduced renal function in patients with chronic myelomonocytic leukemia
por: Heschl, Julia, et al.
Publicado: (2022) -
Significance of abnormal blood coagulation in patients with chronic myelomonocytic leukemia
por: Weinfurtner, Christoph, et al.
Publicado: (2022) -
Significance of C-reactive protein in patients with chronic myelomonocytic leukemia
por: Liang-Fonseca, Jian, et al.
Publicado: (2022) -
Treatment options and survival in real life during the past three decades in patients with chronic myelomonocytic leukemia
por: Reiser, Julia, et al.
Publicado: (2022)